Search Results - "Dahm, A. E. A."

An Exploratory Trial of Cyclooxygenase Type 2 Inhibitor in HIV-1 Infection: Downregulated Immune Activation and Improved T Cell-Dependent Vaccine Responses by PETTERSEN, Frank O, TORHEIM, Eirik A, DAHM, Anders E. A, AABERGE, Ingeborg S, LIND, Andreas, HOLM, Malin, AANDAHL, Einar M, SANDSET, Per M, TASKEN, Kjetil, KVALE, Dag

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Cold agglutinin disease revisited: a multinational, observational study of 232 patients by Berentsen, Sigbjørn, Barcellini, Wilma, D'Sa, Shirley, Randen, Ulla, Tvedt, Tor Henrik Anderson, Fattizzo, Bruno, Haukås, Einar, Kell, Megan, Brudevold, Robert, Dahm, Anders E.A., Dalgaard, Jakob, Frøen, Hege, Hallstensen, Randi Fykse, Jæger, Pernille H., Hjorth-Hansen, Henrik, Małecka, Agnieszka, Oksman, Markku, Rolke, Jürgen, Sekhar, Mallika, Sørbø, Jon Hjalmar, Tjønnfjord, Eirik, Tsykunova, Galina, Tjønnfjord, Geir E.

“…We retrospectively studied 232 patients with cold agglutinin disease (CAD) at 24 centers in 5 countries. In Norway and a northern region of Italy, the study…”
Get full text

Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5'-Flanking Region by Ali, Huda Omar, Stavik, Benedicte, Myklebust, Christiane Filion, Andersen, Elisabeth, Dahm, Anders E A, Iversen, Nina, Sandset, Per Morten, Skretting, Grethe

“…Oestrogens influence the pathology and development of hormone-sensitive breast cancers. Tissue factor pathway inhibitor (TFPI) has been shown to be associated…”
Get full text

Candidate gene polymorphisms and the risk for pregnancy-related venous thrombosis by Dahm, Anders E. A., Bezemer, Irene D., Bergrem, Astrid, Jacobsen, Anne F., Jacobsen, Eva M., Skretting, Grethe, Rosendaal, Frits R., Sandset, Per Morten

“…Summary Venous thrombosis (VT) is one of the leading causes of maternal death in the western world, but the genetic causes of pregnancy‐related VT are…”
Get full text

Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium by Kostovski, Emil, Dahm, Anders EA, Iversen, Nina, Hjeltnes, Nils, Østerud, Bjarne, Sandset, Per Morten, Iversen, Per O

“…We previously found an association between the circadian variation of free tissue factor pathway inhibitor (TFPI) and melatonin in able-bodied males and in men…”
Get full text

Safety of D‐dimer testing as a stand‐alone test for the exclusion of deep vein thrombosis as compared with other strategies by Fronas, S. G., Wik, H. S., Dahm, A. E. A., Jørgensen, C. T., Gleditsch, J., Raouf, N., Klok, F. A., Ghanima, W.

“…Essentials The aim of deep vein thrombosis (DVT) diagnostic work‐up is to maximize both safety and efficiency. We explored whether D‐dimer is safe and…”
Get full text

The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI by Raps, Marjolein, Helmerhorst, Frans M, Fleischer, Kathrin, Dahm, Anders E A, Rosendaal, Frits R, Rosing, Jan, Reitsma, Pieter, Sandset, Per Morten, van Vliet, Huib A A M

“…Use of combined oral contraceptives is associated with a three- to six-fold increased risk of venous thrombosis. Hormonal contraceptives induce acquired…”
Get more information

Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism: a population-based case-control study by Bergrem, Astrid, Dahm, Anders E A, Jacobsen, Anne Flem, Sandvik, Leiv, Sandset, Per Morten

“…Limited data exist on thrombophilia and the risk of venous thrombosis (VT) during pregnancy and postpartum. The objectives of the present study were to…”
Get more information

Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer by Cui, X. Y., Tinholt, M., Stavik, B., Dahm, A. E. A., Kanse, S., Jin, Y., Seidl, S., Sahlberg, K. K., Iversen, N., Skretting, G., Sandset, P. M.

“…Essentials A hypoxic microenvironment is a common feature of tumors that may influence activation of coagulation. MCF‐7 and SK‐BR‐3 breast cancer cells and…”
Get full text

Genetic variations in the annexin A5 gene and the risk of pregnancy‐related venous thrombosis by Dahm, A. E. A., Tiscia, G., Holmgren, A., Jacobsen, A. F., Skretting, G., Grandone, E., Sandset, P. M.

“…Summary Background Annexin A5 is a natural anticoagulant assumed to have thrombomodulary functions as it shields phospholipid layers from coagulation…”
Get full text

A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women by Dahm, Anders E.A, Eilertsen, Anette L, Goeman, Jelle, Olstad, Ole Kristoffer, Øvstebø, Reidun, Kierulf, Peter, Mowinckel, Marie-Christine, Skretting, Grethe, Sandset, Per Morten

“…Abstract Background Postmenopausal hormone therapy is associated with many diseases and conditions, e.g., cardiovascular diseases and asthma, but the…”
Get full text

Circadian rhythms of hemostatic factors in tetraplegia: a double-blind, randomized, placebo-controlled cross-over study of melatonin by Kostovski, E, Dahm, A E A, Mowinckel, M C, Stranda, A, Skretting, G, Østerud, B, Sandset, P M, Iversen, P O

“…Study design: This is a double-blind, randomized, placebo-controlled cross-over study of melatonin in complete tetraplegia. Objectives: Tetraplegic patients…”
Get full text

Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor by VAN VLIET, H. A. A. M., BERTINA, R. M., DAHM, A. E. A., ROSENDAAL, F. R., ROSING, J., MORTEN SANDSET, P., HELMERHORST, F. M.

“…Background: Oral contraceptives (OC) containing different types of progestogens induce different sensitivities to activated protein C (APC) measured with the…”
Get full text

Determinants of the APTT‐ and ETP‐based APC sensitivity tests by VISSER, M. C. H., HYLCKAMA VLIEG, A., TANS, G., ROSING, J., DAHM, A. E. A., SANDSET, P. M., ROSENDAAL, F. R., BERTINA, R. M.

“…Background: A reduced sensitivity for activated protein C (APC) is associated with an increased risk of venous thrombosis even in the absence of the factor…”
Get full text

The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1 by DAHM, A. E. A., SANDSET, P. M., ROSENDAAL, F. R.

Get full text

Elevated Complement C3 and C4 Levels are Associated with Postnatal Pregnancy-Related Venous Thrombosis by Dahm, Anders E A, Jacobsen, Eva Marie, Wik, Hilde Skuterud, Jacobsen, Anne Flem, Mollnes, Tom Eirik, Kanse, Sandip M, Sandset, Per Morten

“…High levels of complement C3 are associated with venous thrombosis (VT) in the general population. We investigated if high C3 and C4 levels were associated…”
Get more information

Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART by Stiksrud, Birgitte, Nowak, Piotr, Nwosu, Felix C, Kvale, Dag, Thalme, Anders, Sonnerborg, Anders, Ueland, Per M, Holm, Kristian, Birkeland, Stein-Erik, Dahm, Anders E A, Sandset, Per M, Rudi, Knut, Hov, Johannes R, Dyrhol-Riise, Anne M, Trøseid, Marius

“…BACKGROUND:Microbial translocation and chronic inflammation may contribute to non-AIDS morbidity in patients with HIV. This study assessed the impact of…”
Get full text

Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study by Theocharides, Alexandre, Gisslinger, Heinz, De Stefano, Valerio, Accurso, Vincenzo, Iurlo, Alessandra, Devos, Timothy, Egyed, Miklos, Lippert, Eric, Delgado, Regina Garcia, Cantoni, Nathan, Dahm, Anders E. A., Sotiropoulos, Damianos, Houtsma, Erik, Smyth, Aoife, Iqbal, Amir, Di Matteo, Paola, Zuurman, Mike, Boekhorst, Peter A. W.

“…Background Hydroxyurea (HU) is a commonly used first‐line treatment in patients with polycythemia vera (PV). However, approximately 15%–24% of PV patients…”
Get full text

Interaction between tissue factor pathway inhibitor and factor V levels on the risk of venous thrombosis by DAHM, A. E. A., BEZEMER, I. D., SANDSET, P. M., ROSENDAAL, F. R.

Get full text

Is venous thromboembolism a problem in patients with cancer in palliative care? by Sandset, Per Morten, Dahm, Anders E A

Get full text